Fundraising Fox
/Companies
Sign in

Indi Molecular

Culver City, US · Founded 2013 · Delaware corporation · 2 employees on LinkedIn · 4 known investors

Find your way into Indi Molecular

Sign up to see every warm intro you have to Indi Molecular

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Indi Molecular team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.

BiotechDeep TechMedical Devices

Founders & leadership

Indi Molecular was founded in 2013 by James Heath.

JH
James HeathFounder
LH
Leroy HoodNamed on SEC filing
AJAndreas Jurgeit
Andreas JurgeitBoard Member2017–2018Partner at Gimv
HA
Heather AgnewNamed on SEC filing
AL
Albert LudererNamed on SEC filing
DC
Darren CaiNamed on SEC filing

Board

DF
Douglas FisherBoard director

Investors · 4

M Ventures✓ confirmed by Indi MolecularAmsterdam · $10.8M

How we know: the company's own site · funding news · press coverage · Not right? Tell us

Asset Management Companylisted by Asset Management CompanyMenlo Park · $500K – $2M

How we know: Asset Management Company's portfolio page · Not right? Tell us

Asset Management VenturesreportedPalo Alto

How we know: press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$4.5M disclosed across 1 of 2 rounds · 2013–2017

  • Undisclosed amountseed roundSep 2013

    InterWest Partners (lead)

    Source ↗
▶$4.5MraisedJun 2017 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leroy HoodDirector
  • Andreas JurgeitDirector
  • James HeathDirector
  • Heather AgnewExecutive Officer
  • Albert LudererExecutive Officer, Director
  • Douglas FisherDirector
  • Darren CaiDirector
Amount sold
$4.5M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

NobelprizeNobelprize.org provides open data about the Nobel Prizes and Nobel Laureates to developers through a REST API and as Linked Data (RDF/SPARQL). The data is free to use, returned in JSON or CSV, and updated alongside the main website including at the time of new Laureate announcements.
TeamTeam USA organizes a media event for capturing content of U.S. Olympic and Paralympic athletes preparing for the Winter Games. The Universal Shoot is an invite-only event that features high-profile American winter sports athletes across disciplines like skiing, snowboarding, and figure skating.
RscThe Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications. It sets standards for chemical scientists, promotes open access to scientific knowledge, and advocates for chemistry's role in addressing societal challenges including healthcare, environmental protection, and clean energy.

Companies working in the same space as Indi Molecular.

In the news

Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Developmentglobenewswire.com · Jun 2017Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partnersfinance.yahoo.com · Sep 2013Indi Molecular - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Indi Molecular do?
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.
Who founded Indi Molecular?
Indi Molecular was founded by James Heath in 2013.
Who are Indi Molecular's investors?
Indi Molecular's investors include Legend Capital, M Ventures, Asset Management Company, Asset Management Ventures.
How much funding has Indi Molecular raised?
Indi Molecular has disclosed $4.5M raised across 1 of its 2 known rounds.
Where is Indi Molecular headquartered?
Indi Molecular is headquartered in Culver City, US.